Physician profile
Pooja Saroha
NPI 1215132691
$3,406.81
in general payments reported to CMS, 2019-2025
7 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 96% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $37.79 · 2021: $902 · 2022: $177 · 2023: $920 · 2024: $193 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119 · Education: $1,025 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.79 |
| Education | $1,025.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,984.56 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $431.94 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $381.52 | 2019-2025 | Arestin, Ossix Plus |
| Dmg America LLC | $379.75 | 2021 | |
| Straumann USA LLC | $197.50 | 2021-2025 | |
| Solventum Corporation | $18.19 | 2025 | 3m Scotchbond, 3m Clinpro |
| Gc America INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Saroha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.